Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffry P Simko

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
European Urology Open Science|January 15, 2025
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate CancerMadison T Baxter, Christopher C Conlin, Aditya Bagrodia, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
European Urology Oncology|February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 TrialAshley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
European Urology Open Science|January 15, 2025
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate CancerMadison T Baxter, Christopher C Conlin, Aditya Bagrodia, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
European Urology Oncology|February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 TrialAshley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
Pageof 10